Bill Text: HI HB2357 | 2022 | Regular Session | Introduced
Bill Title: Relating To Sunscreens.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced - Dead) 2022-01-28 - Referred to EEP/WAL, CPC, FIN, referral sheet 3 [HB2357 Detail]
Download: Hawaii-2022-HB2357-Introduced.html
|
HOUSE OF REPRESENTATIVES |
H.B. NO. |
2357 |
|
THIRTY-FIRST LEGISLATURE, 2022 |
|
|
|
STATE OF HAWAII |
|
|
|
|
|
|
|
|
||
|
|
||
A BILL FOR AN ACT
relating to SUNSCREENS.
BE IT
ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
SECTION 1. Section 342D-21, Hawaii Revised Statutes, is amended to read as follows:
"[[]§342D-21[]] Sale and distribution of
sunscreen containing oxybenzone, avobenzone, octocrylene, or octinoxate[, or both]; prohibition. (a)
Beginning January 1, 2021, it shall be unlawful to sell, offer for sale,
or distribute for sale in the State any sunscreen that contains oxybenzone or
octinoxate, or both, without a prescription issued by a licensed healthcare
provider.
(b)
No county shall enact any ordinance or regulatory restriction to
prohibit the sale, use, labeling, packaging, handling, distribution, or
advertisement of sunscreens containing oxybenzone or octinoxate, or both, prior
to January 1, 2021.
(c) Beginning January 1, 2024, it shall be
unlawful to sell, offer for sale, or distribute for sale in the State any sunscreen
that contains avobenzone or octocrylene without a prescription issued by a
licensed healthcare provider.
(d)
No county shall enact any ordinance or regulatory restriction to
prohibit the sale, use, labeling, packaging, handling, distribution, or advertisement
of sunscreens containing avobenzone or octocrylene prior to January 1, 2024.
[(c)] (e) For purposes of this section:
"Licensed healthcare provider"
means a physician or osteopathic physician licensed pursuant to chapter 453, or
an advanced practice registered nurse licensed pursuant to chapter 457.
"Octinoxate" refers to the chemical (RS)-2-Ethylhexyl (2E)-3-(4-methoxyphenyl)prop-2-enoate under the International Union of Pure and Applied Chemistry chemical nomenclature registry; that has a chemical abstract service registry number 5466-77-3; the synonyms of which include but are not limited to ethylhexyl methoxycinnamate, octyl methoxycinnamate, Eusolex 2292, Neo Heliopan AV, NSC 26466, Parsol MOX, Parsol MCX, and Uvinul MC80; and is intended to be used as protection against ultraviolet light radiation with a spectrum wavelength from 370 nanometers to 220 nanometers in a sunscreen.
"Oxybenzone" refers to the chemical (2-Hydroxy-4-methoxyphenyl)-phenylmethanone under the International Union of Pure and Applied Chemistry chemical nomenclature registry; that has a chemical abstract service registry number 131-57-7; the synonyms of which include but are not limited to benzophenone-3, Escalol 567, Eusolex 4360, KAHSCREEN BZ-3, Uvasorb MET/C, Syntase 62, UV 9, Uvinul 9, Uvinul M-40, Uvistat 24, USAF Cy-9, Uniphenone-3U, 4-methoxy-2-hydroxybenzophenone and Milestab 9; and is intended to be used as protection against ultraviolet light radiation with a spectrum wavelength from 370 nanometers to 220 nanometers in a sunscreen.
"Prescription" means an order for
medication, that is dispensed to or for an ultimate user. "Prescription" shall not include an
order for medication that is dispensed for immediate administration to the
ultimate user, such as a chart order to dispense a drug to a bed patient for
immediate administration in a hospital.
"Prescription" includes an order for a sunscreen.
"Sunscreen" means a product marketed or intended for topical use to prevent sunburn. Sunscreen does not include products marketed or intended for use as a cosmetic, as defined in section 328-1, for the face."
SECTION 2. Statutory material to be repealed is bracketed and stricken. New statutory material is underscored.
SECTION 3. This Act shall take effect upon its approval.
|
INTRODUCED BY: |
_____________________________ |
|
|
|
Report Title:
Avobenzone; Octocrylene; Sunscreen; Prohibition
Description:
Prohibits the distribution and sale of sunscreens containing avobenzone and octocrylene beginning January 1, 2024.
The summary description
of legislation appearing on this page is for informational purposes only and is
not legislation or evidence of legislative intent.
